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Abstract Rods of the Acinetobacter genus are present
mainly in the external environment (e.g. water, soil) and in
animals, while in humans they may comprise physiological
flora. The main pathogenic species is Acinetobacter bau-
mannii complex, which constitutes a common cause of
nosocomial infections, particularly in patients with under-
lying diseases and risk factors (e.g. prior broad-spectrum
antibiotic therapy, malignancy, central venous catheter,
mechanical ventilation); however, infections of the eye
caused by strains of Acinetobacter spp. are very rare. We
report a unique case of community-acquired corneal ulcer
caused by Acinetobacter non-baumannii (possibly A. junii),
in a patient with no risk factors identified. The case high-
lights the need for obtaining a sample from the cornea for
bacteriological culture in the case of suspected ophthalmic
infection as identification of the pathogen, and assessment
of its susceptibility profile enables proper antibiotic ther-
apy, improves the outcome and may constitute an eyesight-
saving management.
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Introduction
Rods of the Acinetobacter genus are Gram-negative coc-
cobacilli. They are present mainly in the external envi-
ronment (e.g. water, soil) and in animals, while in humans
they may comprise physiological flora, particularly in hot
and humid climate countries [1]. The main pathogenic
species is Acinetobacter baumannii complex, which con-
stitutes a common cause of nosocomial infections, partic-
ularly in patients with underlying diseases and risk factors
(e.g. prior broad-spectrum antibiotic therapy, malignancy,
central venous catheter, mechanical ventilation) [1, 2].
However, infections of the eye caused by strains of Aci-
netobacter spp. are uncommon. We present a unique case
of community-acquired Acinetobacter non-baumannii
(possibly A. junii) corneal ulcer in a patient without
recognised risk factors.
Case report
We report a community-acquired corneal ulcer caused by
A. junii in a 51-year-old woman with no significant past
medical history. She was admitted to the E.R. with a
diagnosis of corneal ulcer (ulcerative keratitis) and anterior
uveitis of the right eye. For the previous 2 days she com-
plained of flu-like symptoms and pain of the affected
eyeball. She was generally in good health, with no history
of ophthalmological diseases or treatment. Eight years
earlier she was diagnosed with unexplained anaemia, but
results of the recent blood tests were within the normal
range.
On examination the eyelid and conjunctiva were swol-
len, with deep and superficial conjunctival injection. There
was a large (1/2 of the corneal diameter), white and deep
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inflammatory infiltrate. A 2-mm hypopyon (accumulation
of pus in the anterior chamber) was noticed. Best corrected
visual acuity (BCVA) was 0.2.
Corneal scrapings were taken at presentation for
microbiological examination. A strain of A. junii was iso-
lated in pure culture and identified susceptible to all tested
antimicrobials: aminoglycosides (amikacin, gentamicin,
tobramycin, neomycin), tetracycline, chloramphenicol,
norfloxacin and sulphonamides. The species identification
and susceptibility testing was performed in a clinical
microbiology laboratory using an automated system VI-
TEK 2 Compact (bioMerieux). It should be noted, how-
ever, that according to the present data the identification of
A. junii by this automated system is uncertain, in contrast to
A. baumannii complex [3].
Empiric antibiotic therapy was started on admission and
comprised systemic ciprofloxacin (0.2 g b.d.) and topical
chloramphenicol ointment (q.i.d.). After obtaining the
culture result and an antibiogram of the isolate, this treat-
ment was continued as the strain was susceptible to the
antibiotics used in empiric therapy. In the meantime (whilst
awaiting the culture results) there was a clinical improve-
ment of the condition of the patient’s eye.
Four days later the corneal ulcer continued to diminish
in size and depth, with gradual epithelisation noted in the
periphery of the affected area. Descemet’s membrane folds
decreased substantially and hypopyon virtually resolved,
while fine dust-like deposits were detected on the corneal
endothelium. The infection resolved within 2 weeks, with
only slight opacity, thinning and single pigment granules
still present in the lower nasal quadrant of the cornea. The
patient was discharged with BCVA 0.7.
Discussion
Acinetobacter species are opportunistic pathogens causing
nosocomial infections [2]. Relatively few infections caused
by Acinetobacter spp. are community acquired, reported
primarily from countries with tropical or subtropical cli-
mate, and mainly affected patients with some form of
comorbidity or associated with heavy smoking and excess
alcohol consumption [4, 5]. Clinical forms of Acinetobac-
ter infections include mainly the respiratory tract, blood-
stream infections, peritoneum, urinary tract infection,
surgical wounds, meningitis, skin and soft tissue infections,
while eye infections are rare [2].
The spectrum of ocular infections caused by Acineto-
bacter spp. comprises acute or chronic conjunctivitis,
corneal ulcers and dacryocystitis [6, 7]. Exposure of cor-
nea, use of contact lens, penetrating keratoplasty, and
immunosuppression have been implicated as predisposing
factors to eye infections by Acinetobacter [6]. Rods of the
genus Acinetobacter have been implicated in the aetiology
of endophthalmitis and preseptal cellulitis usually preceded
by bacteraemia [4, 8–10]. Keratitis caused by Acineto-
bacter spp. is rare and may result from trauma, contact lens
wear or ocular surgery, e.g. penetrating keratoplasty—PKP
or cataract surgery [4, 6, 8, 11–13]. In a study reporting 750
cases of postoperative ocular infections, Acinetobacter spp.
comprised 2 % of strains cultured from clinical specimens,
being second most common pathogen (after Pseudomonas)
among Gram-negative bacteria [14]. Interestingly ocular
colonisation with Acinetobacter may precede its appear-
ance in sputum or blood cultures 1–2 days later [15].
Acinetobacter keratitis has also been reported in a patient
with chronic lymphocytic leukaemia [16].
Ocular surface colonisation by Acinetobacter spp. may
be particularly important in sedated intensive care unit
patients [17]. Incomplete lid closure leads to drying of the
conjunctiva and the corneal epithelium, resulting in lesions
ranging from punctate epithelial erosions to a deep ulcer
formation [17].
In some cases infections caused by Acinetobacter spp.
are endogenous, without any obvious predisposing factors
[4, 9]. Clinically these ocular infections take a form of
endophthalmitis or keratitis with or without ulcer formation
[9, 11, 13]. Recently a case of A. baumannii endophthal-
mitis has been reported, which resulted from intravitreal
ranibizumab injection [18]. Eye infections may be caused
by A. baumannii as well as other species such as A. anit-
ratus or A. lwoffii [4, 8, 11]. Newly described Acineto-
bacter species, e.g. A. gyllenbergii-like isolate, have been
implicated in ocular infections as well [7].
Acinetobacter junii rarely causes infections in humans
[19]. In larger analyses from Europe, strains of A. junii
constitute 3.6–4.8 % of all Acinetobacter spp. isolates—
12/331 and 9/186, respectively [20, 21]. It mainly affects
patients who have had prior antimicrobial therapy, invasive
procedures, or malignancy [19]. Out of 34 patients with A.
junii infections 80 % were hospital-acquired; four patients
died (11.4 %) despite adequate antibiotic therapy in three
cases [19]. Only one patient had ocular involvement—
keratitis. Acinetobacter junii has been associated mainly
with bacteremia and sepsis in neonates and paediatric on-
cologic patients [22]. Linde et al. described a case of
catheter-related bloodstream infection caused by A. junii in
an adult oncologic patient [22].
Henao-Martinez et al. [23] described a case of com-
munity-onset non-traumatic cellulitis caused by a strain
identified as A. junii-johnsonii. Corneal perforation due to
A. junii has been reported very rarely [5, 24].
In conclusion it should be noted that A. non-baumannii
species, including A. junii, may cause a community-
acquired corneal ulceration in an otherwise healthy patient.
Ophthalmologists should obtain a sample from the cornea
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for bacteriological culture in the case of suspected infection
as identification of the unique causative pathogen, and its
susceptibility profile enables administration of proper
antibiotic therapy, improves the outcome and may consti-
tute an eyesight-saving management.
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